Plain-English translation of NCT07231601 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a surgical technique called mesenteric excision and exclusion for people with Crohn's disease who need surgery on the terminal ileum (the end part of the small intestine). The approach combines two newer surgical methods—removing the tissue surrounding the affected bowel and reshaping the connection in a special way—both designed to reduce the chance that Crohn's disease will return after surgery.
Even with modern medicines, about half of people with Crohn's disease eventually need surgery, and the disease comes back in roughly 30% of cases within 10 years. This trial exists because early evidence suggests these newer surgical techniques might lower that recurrence rate by targeting the tissue that researchers believe plays a role in disease returning.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive the new surgical procedure at the hospital in Greece. You'll be monitored closely for any complications in the first month after surgery. Then you'll return for follow-up visits at 6 months, 2 years, and 5 years, where doctors will check how you're doing, perform imaging tests, and do endoscopy (a camera test of your bowel) to see if Crohn's disease has returned.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
Greece
Sponsor
Tzaneio General Hospital
Enrollment target
~50 participants
Started
January 2022
Primary completion
December 2027
Age range
16 Years and older
Last updated on clinicaltrials.gov in November 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Panagiotis Dikeakos, Consultant
General Hospital of Piraeus "Tzaneio"
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.